Metronidazole 500mg Tablet Dosing
For trichomoniasis, metronidazole 500 mg twice daily for 7 days is the preferred alternative regimen when the single 2g dose is not suitable, achieving 90-95% cure rates. 1, 2
Primary Indications and Dosing
Trichomoniasis
- Recommended regimen: Metronidazole 2g orally as a single dose
- Alternative regimen: Metronidazole 500 mg twice daily for 7 days 3, 1, 2, 1, 2
The 7-day regimen is particularly important for:
- Women with a history of prior T. vaginalis infection (24.1% vs 12.6% treatment failure with single dose) 4
- Symptomatic patients at baseline (21.4% vs 10.8% failure with single dose) 4
- Patients who cannot be relied upon to avoid reinfection during the treatment period
Both regimens achieve approximately 90-95% cure rates, but the multidose regimen demonstrates superior efficacy in preventing repeat infection at 4-week follow-up 1, 2, 4. The 7-day course may minimize reinfection by providing protection long enough for sexual contacts to obtain treatment 3.
Treatment Failures
If initial treatment fails with either regimen:
- First failure: Retreat with metronidazole 500 mg twice daily for 7 days 3, 2
- Second failure: Metronidazole 2g once daily for 3-5 days 3, 2
- Persistent failure: Consult specialist for susceptibility testing 2
Anaerobic Bacterial Infections
- Standard dosing: 7.5 mg/kg every 6 hours (approximately 500 mg for a 70 kg adult) 5
- Maximum: 4g per 24 hours
- Duration: 7-10 days typically; bone/joint, lower respiratory tract, and endocardium infections may require longer treatment 5
Important note: Recent evidence suggests that dosing every 12 hours may be as effective as every 8 hours for hospitalized patients with anaerobic infections (excluding C. difficile, CNS infections, and amebiasis), though this is based on limited retrospective data 6, 7.
Amebiasis
Adults:
- Acute intestinal amebiasis: 750 mg three times daily for 5-10 days 5
- Amebic liver abscess: 500-750 mg three times daily for 5-10 days 5
Special Populations
Pregnancy
- First trimester: Metronidazole is contraindicated 3
- Second and third trimesters:
Multiple studies and meta-analyses have not demonstrated consistent teratogenic or mutagenic effects with metronidazole use during pregnancy 2.
Hepatic Impairment
Patients with severe hepatic disease metabolize metronidazole slowly, resulting in drug and metabolite accumulation. Doses below usual recommendations should be administered cautiously with close monitoring of plasma levels and toxicity 5.
Renal Impairment
- Decreased renal function does not alter single-dose pharmacokinetics 5
- In anuric patients, dose reduction is not specifically required as metabolites are rapidly removed by dialysis 5
Critical Clinical Considerations
Partner Treatment
Sex partners must be treated concurrently. Patients should avoid sexual intercourse until both patient and partner(s) complete therapy and are asymptomatic 3, 2. Ensuring partner treatment increases cure rates from 90-95% to higher levels 1, 2.
Common Pitfalls
- Topical metronidazole gel is NOT effective for trichomoniasis (efficacy <50%) and should never be used for this indication 2
- Single-dose therapy may result in higher serum levels reaching fetal circulation in pregnancy—avoid this regimen in pregnant patients 5
- Nausea occurs more frequently with three-times-daily dosing compared to twice-daily 7
Drug Interactions
Monitor closely when co-administered with:
- Alcohol (disulfiram-like reaction)
- Warfarin (enhanced anticoagulation)
- Phenytoin (altered metabolism) 8
HIV-Infected Patients
Patients with HIV should receive identical treatment regimens as HIV-negative patients for both trichomoniasis and bacterial vaginosis 3, 2.